SUMMARY The inter-and intralaboratory quality control of haemoglobin estimation in remote laboratories requires a more rugged control haemolysate than is commercially available. The stabilities of oxyhaemoglobin and carboxyhaemoglobin forms of an ethanediol-containing haemolysate were studied over a three-year period. From the results obtained, carboxyhaemoglobin under nitrogen is proposed as a possible candidate reference material for haemoglobin assay. Van Assendelft et all discussed an interlaboratory trial of quality control in haemoglobinometry and recommended that full intralaboratory control should incorporate the use of concentrated haemoglobin solutions, and that there should be frequent use ofhaemiglobincyanide (HiCN) reference solutions and checking the CN-content of the reagent.
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They measured the haemoglobin content of a commercially available haemolysate (Merz and Dade AG, Bern, Switzerland), kept at 4'C over a period of 12 months, at monthly intervals, and using a new bottle of haemolysate for each measurement. During that time, which was the manufacturer's recommended period of stability, the haemoglobin content appeared to decrease by 0-2 g/dl.
Van Assendelft et all stressed the need for concentrated haemoglobin haemolysates to be kept free from bacterial contamination and noted that the Merz Toluene (40 ml) was added to each 100 ml of haemolysate and mixed (Waring Blendor) for two minutes. The mixture was centrifuged at 2075 g for 30 min, causing the cellular material to form a tight mat of precipitate between the aqueous haemolysate and the toluene. The toluene was discarded and the haemolysate filtered through glass wool; toluene was again added in the ratio of two volumes of toluene to five volumes of haemolysate. The solutions were mixed and centrifuged as before, the toluene discarded and the haemolysate again filtered through glass wool.
The haemolysate was concentrated in dialysis tubing in a stream of air from an electric fan for 4 h. This gave a solution with a haemoglobin concentration of 29 g/dl. The volume of concentrated haemolysate was measured and a half-volume of ethanediol was added to make a final solution which contained 33 % vol/vol ethanediol.
Oxyhaemoglobin
Oxygen was bubbled slowly through a well-stirred portion of stock haemolysate solution for 30 min: 1-0 ml portion of the oxygenated solution were then dispensed into 5 0 ml clear soda glass vials. The contents were overlaid with oxygen, and the vials sealed and stored at -30°C.
Carboxyhaemoglobin
Carbon monoxide was bubbled slowly through a portion of stirred stock haemolysate in an efficient fume cupboard for 30 min: 1I0 ml portion were dispensed into 5 0 ml clear glass ampoules, overlaid with nitrogen, sealed and stored at -30°C.
METHODS

Experimental design
Batches of 88 ampoules of carboxyhaemoglobin and 20 ampoules of oxyhaemoglobin were made available for long term stability testing. The ampoules were divided into four groups to be stored respectively at -30°C,4°C, room temperature (RT 11-26°C overthe trial period) and 40°C. Before being placed at these temperatures, the contents of half the ampoules of each group were transferred aseptically into sterile 5.0 ml bijou bottles. There were two reasons for this manoeuvre:
(1) to establish whether storage under gas in a sealed ampoule was really necessary for long-term stability; (2) to establish whether subsampling caused evaporation losses or contamination by micro-organisms, or both.
Being aware of the problems associated with sample viscosity when using piston-operated air interface micropipettes,7 the dilutions of haemolysate were conveniently made using a 20 ,ul positive displacement microlitre diluting device, the SwizzleStick.5
Procedure The groups of ampoules and bottles were placed at their respective temperatures in May 1978. Visual inspection of ampoules and bottles after 24 h at 40'C revealed no obvious change, but after 72 h at 40°C, small "clots" had appeared in the ampoules and bottles of both the oxyhaemoglobin and carboxyhaemoglobin haemolysates; these were not investigated further.
The first haemoglobin measurements were made after three weeks. One ampoule and one bottle were selected at random from each of the -30°C, 4°C and RT groups. The ampoules were labelled HbCO IA and the bottles, HbCO IB, for each temperature. The -30°C and 4°C ampoules were allowed to equilibrate to room temperature, when the contents of the ampoules from the three temperatures were transferred aseptically into sterile bijou bottles, appropriately labelled. Dilutions (1/201) were made with haemiglobincyanide diluent and a period of two hours was allowed for complete conversion into haemiglobincyanide.8 The absorbances of the diluted solutions and of the ICSH haemiglobin reference solution were measured at 540 nm and the haemoglobin content calculated. Once the dilutions had been made, the capped bottles with remaining contents were replaced at the appropriate temperature.
The second series of measurements was made after 12 wk. Bottles HbCO IA and 1B from each group were re-examined, in conjunction with another ampoule, HbCO 2A and bottle, HbCO 2B from the -30°C, 4°C and RT groups. The procedure was the same as before, but the dilutions of the RT samples showed an insoluble granular precipitate and were unsuitable for absorbance measurements.
The third series of measurements took place at 38 wk. Bottles HbCO IA, IB, 2A and 2B from each group were re-examined, in conjunction with another ampoule, HbCO 3A and bottle, HbCO 3B from each of the -30°C, 4°C and RT groups. The RT samples were diluted and visually examined. As the insoluble granular precipitate was present in all of the tubes, their absorbances were not measured and all the ampoules and bottles being stored at RT were discarded.
The final series of measurements took place at 165 wk. All the remainingampoules and bottles at-30°C and 4°C that had not been previously sampled were examined, together with the remaining haemolysates of the earlier studies.
Results
The results are shown in Table 1 Remaining ampoules group.bmj.com on October 14, 2017 -Published by http://jcp.bmj.com/ Downloaded from able stability for at least three years when measured by the haemiglobincyanide method, but there was a trend towards an apparent small increase in haemoglobin concentration as judged by the known reproducibility of the method (0 7%);5 this increase may have been an artefact of incipient turbidity. The increase was greater if air was not rigorously excluded by an oxygen overlay.
At room temperature (1 1-26°C), the preparation was stable for 8 wk, as measured with the haemiglobincyanide method but had deteriorated by 38 wk. At 40°C, the preparation was stable for 24 h but had deteriorated by 72 h.
The carboxyhaemoglobin haemolysate stored under nitrogen at -30°C or 4°C was found to be unconditionally stable for at least three years. When the nitrogen overlay was removed, haemiglobin formed and the haemoglobin concentration, as measured by the haemiglobincyanide method, apparently increased.
The carboxyhaemoglobin haemolysate with nitrogen overlay satisfied the criteria of Lewis,2 as outlined above, for an ideal lysed blood reference material. It does have the disadvantage, when used with the ICSH diluent, of requiring two hours for complete conversion into haemiglobincyanide compared with a 3-5 min conversion time for blood samples which normally contain less than 3 % carboxyhaemoglobin. However, complete conversion of the carboxyhaemoglobin haemolysate appears to take place in under one minute in the Coulter counter S when Isoton II and Lyse S are used as the diluent, but the kinetics of the conversion were not investigated.
The ICSH recommended diluent for haemiglobincyanide has been used extensively since it was proposed by van 
